SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2002
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
------------- --------------
Commission File Number: 1-13263
Castle Dental Centers, Inc.
(Exact name of registrant as specified in its charter)
DELAWARE 76-0486898
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
3701 Kirby Drive, Suite 550 77098
Houston, Texas (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (713) 490-8400
N/A
(Former name, former address and former fiscal year, if changed since last year)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No_________
---------
The number of shares of Common Stock issued and outstanding, par value,
$0.001 per share, as of August 12, 2002 was 6,417,206.
CASTLE DENTAL CENTERS, INC.
Index
Page
-----------------
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets
December 31, 2001 and June 30, 2002............................................... 3
Condensed Consolidated Statements of Operations
For the Three and Six Months Ended June 30, 2001 and 2002 ........................ 4
Condensed Consolidated Statements of Cash Flows
For the Six Months Ended June 30, 2001 and 2002................................... 5
Notes to Condensed Consolidated Financial Statements.............................. 6
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations..................................... 14
Item 3. Quantitative and Qualitative Disclosures About Market Risks................. 21
PART II. OTHER INFORMATION
Item 1. Legal Proceedings .......................................................... 21
Item 2. Changes in Securities and Use of Proceeds ................................. 22
Item 3. Defaults Upon Senior Securities............................................. 22
Item 4. Submission of Matters to a Vote of Security Holders......................... 23
Item 5. Other Information........................................................... 23
Item 6. Exhibits and Reports on Form 8-K............................................ 23
SIGNATURES........................................................................................ 26
2
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements
CASTLE DENTAL CENTERS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in thousands, except per share data)
December 31, June 30,
2001 2002
----------------- ----------------
ASSETS
Current assets:
Cash and cash equivalents .................................................... $ 3,979 $ 2,004
Patient receivables, net ..................................................... 4,810 5,705
Unbilled patient receivables, net ............................................ 2,869 2,790
Prepaid expenses and other current assets .................................... 1,373 1,974
-------------- -------------
Total current assets ............................................. 13,031 12,473
-------------- -------------
Property and equipment, net .................................................. 14,746 13,455
Goodwill and intangibles, net ................................................ 54,994 17,960
Other assets ................................................................. 1,311 1,022
-------------- -------------
Total assets ..................................................... $ 84,082 $ 44,910
============== =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term debt ............................................ $ 63,759 $ 1,135
Accounts payable and accrued liabilities ..................................... 16,983 18,044
Deferred compensation payable, related party ................................. 132 132
-------------- -------------
Total current liabilities ........................................ 80,874 19,311
-------------- -------------
Long-term debt, net of current portion ......................................... 16 62,418
Commitments and contingencies
Stockholders' equity:
Common stock, $.001 par value, 19,000,000 shares authorized,
6,417,206 shares issued and outstanding ..................................... 6 6
Additional paid-in capital ................................................... 42,086 41,916
Accumulated deficit .......................................................... (38,900) (78,741)
-------------- -------------
Total stockholders' equity ....................................... 3,192 (36,819)
-------------- -------------
Total liabilities and stockholders' equity ....................... $ 84,082 $ 44,910
============== =============
The accompanying notes are an integral part of the consolidated financial
statements.
3
CASTLE DENTAL CENTERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in thousands, except per share data)
Three Months Ended Six Months Ended
June 30, June 30,
-------------------------- --------------------------
2001 2002 2001 2002
------------ ------------- ------------ ------------
Net patient revenues ............................................. $24,504 $25,146 $52,227 $ 50,634
Expenses:
Dentist salaries and other professional costs .................. 6,629 7,327 13,981 14,576
Clinical salaries .............................................. 4,852 5,512 9,985 11,167
Dental supplies and laboratory fees ............................ 2,856 2,960 5,804 5,961
Rental and lease expense ....................................... 1,683 1,540 3,415 3,062
Advertising and marketing ...................................... 805 460 1,588 1,300
Depreciation and amortization .................................. 1,670 903 3,396 1,818
Other operating expenses ....................................... 1,811 2,029 3,712 3,984
Bad debt expense ............................................... 1,164 1,106 2,312 1,883
Restructuring costs and other charges .......................... 1,323 658 1,789 1,184
General and administrative ..................................... 2,722 2,585 5,358 5,356
Asset impairment ............................................... 534 - 534 104
------------ ------------- ------------ ------------
Total expenses ............................................. 26,049 25,080 51,874 50,395
------------ ------------- ------------ ------------
Operating income (loss) .......................................... (1,545) 66 353 239
Interest expense ................................................. 2,158 1,645 4,358 3,273
Other income ..................................................... (17) (180) (26) (193)
------------ ------------- ------------ ------------
Loss before provision for income taxes and
cumulative effect of change in accounting principle ............ (3,686) (1,399) (3,979) (2,841)
Provision for income taxes ....................................... - - - -
------------ ------------- ------------ ------------
Loss before cumulative effect of change
in accounting principle ........................................ (3,686) (1,399) (3,979) (2,841)
Cumulative effect of change in accounting principle .............. - - (250) (37,000)
------------ ------------- ------------ ------------
Net loss ......................................................... $(3,686) $(1,399) $(4,229) $ (39,841)
============ ============= ============ ============
Loss per common share:
Loss before cumulative effect of change
in accounting principle ...................................... $ (0.57) $ (0.22) $ (0.62) $ (0.44)
Cumulative effect of change in accounting principle ............ - - (0.04) (5.77)
------------ ------------- ------------ ------------
Net loss ....................................................... $ (0.57) $ (0.22) $ (0.66) $ (6.21)
============ ============= ============ ============
Weighted average number of common and
common equivalent shares outstanding
Basic and diluted .............................................. 6,417 6,417 6,417 6,417
============ ============= ============ ============
The accompanying notes are an integral part of the consolidated financial
statements.
4
CASTLE DENTAL CENTERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
Six Months Ended
June 30,
------------------------------------
2001 2002
----------------- -----------------
Cash flows from operating activities:
Net loss ............................................................. $ (4,229) $ (39,841)
Adjustments:
Provisions for bad debts ......................................... 2,312 1,883
Depreciation and amortization .................................... 3,396 1,818
Amortization of loan cost ........................................ 208 367
Asset impairment ................................................. 534 104
Gain on sale of property and equipment ........................... - (173)
Cumulative effect of change in accounting principle .............. 250 37,000
Changes in operating assets and liabilities:
Patient receivables ............................................ 60 (2,797)
Unbilled patient receivables ................................... 32 98
Prepaid expenses and other current assets ...................... (314) (551)
Other assets ................................................... 11 (6)
Accounts payable and accrued liabilities ....................... 1,086 1,061
---------- ----------
Net cash provided by (used in) operating activities ....... 3,346 (1,037)
---------- ----------
Cash flows used in investing activities:
Capital expenditures ............................................... (337) (597)
---------- ----------
Net cash used in investing activities ...................... (337) (597)
---------- ----------
Cash flows from financing activities:
Repayment of debt and capital lease obligations .................... (200) (99)
Debt and equity issuance costs ..................................... - (242)
---------- ----------
Net cash used in financing activities ....................... (200) (341)
---------- ----------
Net change in cash and cash equivalents .............................. 2,809 (1,975)
Cash and cash equivalents, beginning of period ....................... 901 3,979
---------- ----------
Cash and cash equivalents, end of period ............................. $ 3,710 $ 2,004
========== ==========
The accompanying notes are an integral part of the consolidated financial
statements.
5
CASTLE DENTAL CENTERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation:
Corporate Organization and Basis of Presentation
The accompanying consolidated financial statements of the Company have
been prepared on a going concern basis, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course of business. The
Company incurred net losses of $19.1 million in 2000, $14.8 million in 2001 and
$2.8 million before cumulative effect of change in accounting principle for the
six-month period ended June 30, 2002. At June 30, 2002, the Company has a
working capital deficit of $6.8 million and had negative cash flows from
operations of $1.0 million for the six months ended June 30, 2002. As discussed
below (Note 2), in July 2002, the Company completed a restructuring of its
credit agreement, senior subordinated notes, subordinated convertible notes and
other indebtedness. This restructuring extinguished certain debt due by the
Company and extended payment dues by the Company on more favorable terms.
Management believes this is an important step in its plan for the Company.
The Company has implemented a plan to improve operating results.
Components of this plan include: (i) increased hiring of new dentists and
improving dentist retention; (ii) continuing to monitor and close unprofitable
and under-performing dental centers; (iii) refurbishing and modernizing existing
dental centers within capital expenditure constraints; (iv) upgrading dental
office management personnel; and (v) improving patient services in order to
increase patient retention rates.
However, there can be no assurance that these efforts to improve
operating results and cash flows will be sufficient to allow the Company to meet
its obligations in a timely manner. Therefore, there is substantial doubt about
the Company's ability to continue in existence. The consolidated financial
statements do not include any adjustments relating to the recoverability and
classification of recorded asset amounts or the amount and classification of
liabilities that might be necessary should the Company be unable to continue in
existence.
The Company provides administrative and management services, non-healthcare
personnel, facilities and equipment to professional corporations in Texas,
Florida, California and Tennessee ("affiliated dental practices") under
long-term management services agreements.
The consolidated financial statements include the accounts of the Company
and all wholly owned and beneficially-owned subsidiaries and the accounts of
affiliated dental practices in which the Company has a long-term controlling
financial interest. Because of corporate practice of medicine laws in the states
in which the Company operates, the Company does not own dental practices but
instead enters into exclusive long-term management services agreements
("Management Services Agreements") with professional corporations that operate
the dental practices. In addition, the Company has the contractual right to
designate, upon the occurrence of certain events, the licensed dentist who is
the majority shareholder of the capital stock of the professional corporation at
a nominal cost ("nominee arrangements"). At June 30, 2002, all of the affiliated
dental practices were owned by dentists with whom the Company had a nominee
arrangement. Under the Management Services Agreements, the Company establishes
annual operating and capital budgets for the professional corporations and
compensation guidelines for the licensed dental professionals. The Management
Services Agreements have initial terms of twenty-five years. The management fee
charged by the Company to an affiliated dental practice is intended to reflect
and is based on the fair value of the management services rendered by the
Company to the affiliated dental practice. Subject to applicable law, the
management fee earned by the Company, except from professional corporations
located in California, is generally comprised of three components: (i) the costs
incurred by it on behalf of the affiliated dental practice; (ii) a base
management fee ranging from 15.0% to 20.0% of net patient revenues; and, (iii) a
performance fee equal to the net patient revenues of the affiliated dental
practice less (a) the expenses of the affiliated dental practice and (b) the sum
of (i) and (ii), as described in the agreements. In California, the Company is
paid a monthly management fee comprised of two components: (i) the costs
incurred by it on behalf of the affiliated dental practice and (ii) a management
fee in an amount equal to 30.0% of net patient revenues. The amount of the
management fee is reviewed by the Company and the affiliated dental practice at
least annually in order to determine whether
6
such fee should be adjusted to continue to reflect the fair value of the
management services rendered by the Company.
Through the Management Services Agreements and the nominee arrangements,
the Company has a significant long-term controlling financial interest in the
affiliated dental practices and, therefore, according to Emerging Issues Task
Force Issue No. 97-2, "Application of FASB Statement No. 94, Consolidation of
All Majority-Owned Subsidiaries, and APB No. 16, Business Combinations, to
Physician Practice Management Entities and Certain Other Entities with
Contractual Management Agreements," consolidates the results of the affiliated
practices with those of the Company. Net patient revenues are presented in the
accompanying statement of operations because the Company must present
consolidated financial statements. All significant intercompany accounts and
transactions, including management fees, have been eliminated in consolidation.
The accompanying unaudited consolidated financial statements as of June 30,
2002, and for the six months ended June 30, 2001 and 2002 include the accounts
of the Company and its management company subsidiaries and the affiliated dental
practices. Pursuant to the rules and regulations of the Securities and Exchange
Commission, certain information and footnote disclosures normally included in
annual financial statements prepared in accordance with generally accepted
accounting principles have been omitted. The unaudited consolidated financial
statements have been prepared consistent with the accounting policies reflected
in the Company's annual financial statements included in the Company's Form 10-K
filed with the Securities and Exchange Commission and should be read in
conjunction therewith. In management's opinion, the unaudited consolidated
financial statements include all adjustments, consisting of normal recurring
adjustments, considered necessary for a fair presentation of such financial
statements. Interim results are not necessarily indicative of results for a full
year.
Recent Accounting Pronouncements
On August 16, 2001, the Financial Accounting Standards Board issued SFAS
143, "Accounting for Asset Retirement Obligation". SFAS 143 addresses financial
accounting and reporting for obligations associated with the retirement of
tangible long-lived assets and the associated asset retirement costs. These
provisions of SFAS 143 are effective for financial statements issued for fiscal
years beginning after June 15, 2002. Earlier application is encouraged.
Management believes the application of SFAS 143 will not have a material effect
on the Company.
On October 3, 2001, the Financial Accounting Standards Board issued SFAS
144, "Accounting for the Impairment or Disposal of Long-Lived Assets". SFAS 144
addresses financial accounting and reporting for the impairment or disposal of
long-lived assets. This Statement supercedes SFAS 121, "Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of" and
the accounting and reporting provisions of APB Opinion No. 30, "Reporting the
Results of Operations-Reporting the Effects of Disposal of a Segment of a
Business, and Extraordinary, Unusual and Infrequently Occurring Events and
Transactions", both of which address the disposal of a segment of a business.
The provisions of SFAS 144 are effective for financial statements issued for
fiscal years beginning after December 15, 2001 and interim periods within those
fiscal years, with early application encouraged. The Company is currently
evaluating the impact of the adoption of this Statement but does not believe it
will have a material impact on the Company's net income, cash flows, or
financial condition.
In May 2002, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 145 ("SFAS 145"), "Rescission of FAS Nos. 4,
44, and 64, Amendment of FAS 13, and Technical Corrections as of April 2002."
This Statement rescinds FASB Statement No. 4, Reporting Gains and Losses from
Extinguishment of Debt, and an amendment of that Statement, FASB Statement No.
64, Extinguishment of Debt Made to Satisfy Sinking-Fund Requirements. This
Statement also rescinds FASB Statement No. 44, Accounting for Intangible Assets
of Motor Carriers. This Statement also amends other existing authoritative
pronouncements to make various technical corrections, clarify meanings, or
describe their applicability under changed conditions. The Company is currently
evaluating the impact of the adoption
7
of this Statement but does not believe it will have a material impact on the
Company's net income, cash flows, or financial condition.
In July 2002, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 146 ("SFAS 146") "Accounting for Costs
Associated with Exit or Disposal Activities". SFAS 146 requires that a liability
for a cost associated with an exit or disposal activity be recognized when the
liability is incurred rather than at the date of a commitment to an exit or
disposal plan. Examples of costs covered by this guidance include termination
benefits provided to current employees that are involuntarily terminated under
the terms of a benefit arrangement that, in substance, is not an ongoing benefit
arrangement or an individual deferred compensation contract, costs to terminate
a contract that is not a capital lease, costs to consolidate facilities or
relocate employees. The provisions of SFAS 146 are effective for exit or
disposal activities that are initiated after December 31, 2002, with earlier
application encouraged. The Company is currently evaluating the impact of the
adoption of this Statement but does not believe it will have a material impact
on the Company's net income, cash flows, or financial condition.
2. Restructuring
Since June 2000, the Company has been in default under:
. its bank credit agreement of $45.2 million (the "Old Credit
Agreement") with its senior secured lenders (the "Senior Secured
Lenders");
. its senior subordinated notes and subordinated convertible notes of
$15.0 million (the "Senior Subordinated Notes") issued to Heller
Financial, Inc. ("Heller") and Midwest Mezzanine Fund II, L.P.
("Midwest," and, collectively with Heller, the "Senior Subordinated
Lenders"); and
. its subordinated notes and other subordinated indebtedness of $3.2
million issued to various sellers of dental practices to the
Company (collectively, the "Old Notes").
On July 19, 2002, the Company entered into a restructuring (the
"Restructuring") with its Senior Secured Lenders, its Senior Subordinated
Lenders and the holders of the Old Notes regarding the debt outstanding under
the Old Credit Agreement, the Senior Subordinated Notes and the Old Notes.
Pursuant to the Restructuring, the Company has:
. exchanged 32,002 shares of Convertible Preferred Stock, Series A-1
(Note 4), par value $.001 per share ("Series A-1 Stock"), for
$3,624,771 in aggregate principal and interest of its Old Notes;
. exchanged 179,280 shares of Series A-1 Stock for $17,928,000 in
aggregate principal and interest of the Senior Subordinated Notes;
. amended and restated the Old Credit Agreement (Note 4);
. issued warrants to purchase 60,859 shares of Convertible Preferred
Stock, Series A-2 (Note 4), par value $.001 per share ("Series A-2
Stock"), to the Senior Secured Lenders;
. borrowed $1,700,000 from the Senior Subordinated Lenders and James
M. Usdan, the Company's Chief Executive Officer (collectively with
the Senior Subordinated Lenders, the "New Money Lenders");
. issued convertible notes with an aggregate principal amount of
$1,700,000 evidencing the amount borrowed from the New Money
Lenders which notes are initially convertible into 3,105,618 shares
of the Company's common stock, par value $.001 per share ("Common
Stock"), interest at 15% is due quarterly and principal is due June
30, 2007;
. issued warrants to purchase 17,974,062 shares of Common Stock to
the New Money Lenders.
The Company expects to recognize a gain of approximately $16.0 million in
the third quarter of 2002 as part of the Restructuring.
As these events did not occur prior to June 30, 2002 the related impact is
not reflected in the accompanying June 30, 2002, Condensed Consolidated Balance
Sheets or Condensed Consolidated Statements of Operations.
In connection with the Restructuring, the Company entered into
settlement agreements ("Settlement Agreements") with Jack H. Castle, Jr. and the
estate of Jack H. Castle, D.D.S. Mr. Castle served as our Chief Executive
Officer until February 2001 and continued as our Chairman of the Board until
July 1, 2001. Dr. Castle owned all of the capital stock of Castle Dental
Associates of Texas, P.C. (formerly Jack H. Castle,
8
D.D.S., P.C.), the professional corporation that employs the affiliated dentists
in the State of Texas (the "Texas PC"), until his death in May 2002, at which
time a successor owner of the Texas PC was appointed.
The Settlement Agreement provided for mutual releases of any claims that
either party may have had, as well as the following terms: (i) Dr. Castle's
estate waived the right to receive the final payment of $0.1 million due under a
deferred compensation agreement; (ii) the Company paid Mr. Castle severance
through June 30, 2002 of approximately $0.3 million, reimbursed him for medical
insurance and forgave $45,000 of debt Mr. Castle owed to the Company; (iii) in
August 2002, Mr. Castle acquired two offices located in Corpus Christi and one
office located in Beaumont and the Company paid Mr. Castle an additional $54,000
of expenses; and (iv) effective June 30, 2002, the Company terminated a lease of
a property held by Goforth, Inc., which is owned by Mr. Castle, that required
payments of approximately $16,000 per month and had a remaining term of
approximately five years.
3. Goodwill and Intangibles
On July 20, 2001, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards (SFAS) No. 141, Business Combinations and SFAS
No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 supercedes APB
Opinion No. 16, Business Combinations, to prohibit use of the
pooling-of-interest (pooling) method of accounting for business combinations
initiated after the issuance date of the final Statement. SFAS No. 142
supercedes APB Opinion No. 17, Intangible Assets, by stating that goodwill will
no longer be amortized, but will be tested for impairment in a manner different
from how other assets are tested for impairment. SFAS No. 142 establishes a new
method of testing goodwill for impairment by requiring that goodwill be
separately tested for impairment using a fair value approach rather than an
undiscounted cash flow approach.
The Company adopted SFAS 142 effective January 1, 2002, and has
reclassified approximately $54.9 million from management services agreements to
goodwill. Under SFAS No. 142, substantially all of the Company's goodwill is no
longer amortized, and the Company must perform an annual impairment test for
goodwill and intangible assets. The Company allocates goodwill to its four
reporting units. SFAS No. 142 requires the Company to compare the fair value of
the reporting unit to its carrying amount on an annual basis to determine if
there is potential impairment. If the fair value of the reporting unit is less
than its carrying value, an impairment loss would be recorded to the extent of
that difference. The Company based the fair values of its reporting units on
discounted cash flow methodology and other company comparisons. The Company used
the services of an outside consultant in preparation of the fair market analysis
of the reporting units. Under SFAS No. 142, the Company recorded a transitional
goodwill impairment charge of $37.0 million, presented as a cumulative effect of
accounting change at the beginning of the fiscal year. This impairment charge is
attributable to market declines in its reporting units in Texas, Florida,
California and Tennessee.
9
The following unaudited pro forma information presents the net loss and net
loss per common share adjusted for SFAS No. 142 (in thousands):
Three Months Ended Six Months Ended
June 30, June 30,
--------------------- ---------------------
2001 2002 2001 2002
-------- --------- -------- --------
Net loss:
Reported loss before cumulative effect of change
in accounting principle ................................. (3,686) (1,399) (3,979) (2,841)
Add back: goodwill amortization, net of tax .............. 682 - 1,366 -
-------- --------- -------- --------
Adjusted loss before cumulative effect of change
accounting principle .................................... (3,004) (1,399) (2,613) (2,841)
Cumulative effect of change in accounting
principle ............................................... - - (250) (37,000)
-------- --------- -------- --------
Adjusted net loss .......................................... $ (3,004) $ (1,399) $ (2,863) $(39,841)
======== ========= ======== ========
Basic and Diluted loss per common share:
Reported loss before cumulative effect of change
in accounting principle ................................. $ (0.57) $ (0.22) $ (0.62) $ (0.44)
Adjusted loss before cumulative effect of change
in accounting principle ................................. (0.47) (0.22) (0.41) (0.44)
Adjusted net loss ........................................ (0.47) (0.22) (0.45) (6.21)
The balance of goodwill subsequent to the recognition of the
transitional goodwill impairment charge above is $17.9 million at June 30, 2002.
4. Long-term Debt and Capital Lease Obligations:
In connection with the Restructuring, the Company entered into a Second
Amended and Restated Credit Agreement ("Credit Agreement") with the Senior
Secured Lenders. Pursuant to the terms of the Credit Agreement, the aggregate
unpaid principal balance of the Old Credit Agreement amounting to $45.2 million
plus accrued and unpaid default interest and other obligations of $2.2 million
have been converted to a term loan in the amount of $47.4 million. Principal of
the Credit Agreement is payable quarterly in installments of $0.5 million
beginning March 31, 2003, increasing to $1.0 million March 31, 2004, and $1.6
million March 31, 2005 with a final payment of the remaining principal balance
due July 19, 2005. As defined in the Credit Agreement, the Company is required
to make an annual cash flow payment and other mandatory prepayments. Interest,
payable monthly, is computed at the bank's prime rate plus two percent. An
administrative fee of $25,000 is payable annually with the first payment due on
July 19, 2002. Fees include (1) a one percent restructuring fee totaling
approximately $0.5 million, which is payable in four quarterly installments of
$0.1 million plus accrued interest at the bank's prime rate plus two percent,
beginning September 19, 2002 and (2) a four percent financing fee amounting to
approximately $1.9 million, which will be payable in full, without interest, on
July 19, 2005. The Credit Agreement contains affirmative and negative covenants
that require the Company to maintain certain financial ratios, limit the amount
of additional indebtedness, limit the creation or existence of liens, set
certain restrictions on acquisitions, mergers and sales of assets and restrict
the payment of dividends.
At June 30, 2002, $45.2 million was outstanding under the Old Credit
Agreement. The balance has been classified between current and long-term based
upon the payment terms of the Credit Agreement entered into in July 2002. At
June 30, 2002, $15.0 million in principal was outstanding under the Senior
Subordinated
10
Notes and $3.2 million in principal was outstanding under the Old
Notes. These balances have been classified as long-term as they are converted to
equity in July 2002, therefore, there is no current payment obligation under
Senior Subordinated Notes and Old Notes.
5. Preferred Stock
The Company has authorized 1,000,000 shares of preferred stock, of which no
shares were outstanding prior to the Restructuring. In connection with
Restructuring (Note 2), the Company established a series consisting of 214,000
shares of Convertible Preferred Stock Series A-1 Stock and a series consisting
of 62,000 shares of Convertible Preferred Stock, Series A-2 Stock. The Series
A-1 Stock is convertible into a number of shares of common stock such that if
the Series A-1 Stock were converted immediately prior to the issuance of (a)
management options, (b) board member options, (c) warrants to the Senior Secured
Lenders, (d) warrants to the New Money Lenders, and (e) Convertible Notes to the
New Money Lenders, the holders of Series A-1 Stock would own 86% of the
outstanding common stock following such conversion. The Series A-1 Stock has
customary anti-dilution protection with regard to such events as stock splits
and stock dividends. Upon liquidation, a holder of a share of Series A-1 Stock
is entitled to a preferential distribution in liquidation equal to $100. The
Series A-2 Stock that will be issued to the Senior Secured Lenders upon exercise
of their warrants to be issued in connection with the Restructured Credit
Agreement will have an aggregate liquidation preference equal to 12% of the
aggregate liquidation preference of all shares of Series A-1 Stock and Series
A-2 Stock outstanding at the closing of the Restructuring.
Each share of Series A-1 Stock and Series A-2 Stock is currently
convertible into approximately 182.7 shares of Common Stock and, once issued,
votes on an "as converted" basis on all matters submitted to the holders of
Common Stock of the Company. Holders of Series A-1 Stock, are entitled to elect
a majority of the directors of the Company.
As of July 19, 2002, the Company does not have enough shares of common
stock authorized for the conversion rights issued in connection with the
Restructuring. The Company plans to either increase the number of authorized
shares of common stock or decrease the number of common shares outstanding or
subject to conversion rights through a reverse stock split at an annual
stockholders meeting to be held in the fourth quarter of 2002.
6. Commitments and Contingencies:
Litigation
On May 30, 2002, litigation was filed in the Circuit Court for Putnam
County, Tennessee against the Company and one of its subsidiaries by the spouse
and children of a patient of an affiliated dental practice alleging that the
defendants were negligent and vicariously liable in the care and treatment of
the patient, resulting in his death. The lawsuit seeks damages in the amount of
$10 million, in excess of the policy limits of $1.0 million per occurrence
carried by the Company. The Company has filed a response to the litigation
denying liability in this matter and intends to vigorously defend itself.
Discovery has not yet commenced in the case and, at this time, the Company
cannot determine what liability, if any, may be assessed against it and
therefore has not recorded any liability in this matter. A finding against the
Company in excess of the insurance policy limits could have a material adverse
effect on the Company.
In 2000, the Company recorded litigation expenses of $1.5 million resulting
from an arbitration award against two subsidiaries of the Company in an
arbitration proceeding in Los Angeles, California. The arbitrator found that the
subsidiaries had breached a contractual agreement to acquire a dental practice
and awarded the plaintiffs actual damages and costs of $1.1 million, plus
interest at 10 percent from the date that the judgment was filed. In connection
with the July 2002 Restructuring, the Company entered into a forbearance
agreement with the plaintiffs regarding this judgment. The Company has agreed
that in exchange for forbearance in enforcing the judgment the Company will make
the following payments (1) $100,000 interest payment in July 2002, (2)
twenty-three monthly installments of $30,000 each and (3) then $25,000
11
monthly installments until paid in full.
In October 2001, the former owners of Dental Centers of America filed suit
in Bexar County, Texas alleging that the Company breached a letter agreement
offering payment as settlement for past due amounts on two subordinated
promissory notes that were part of the purchase consideration for Dental Centers
of America. The plaintiffs obtained a judgment for $625,000 plus interest and
attorneys' fees, against the Company. In connection with the Restructuring the
suit was settled.
The Company also is a defendant in a lawsuit with a landlord of a leased
property that was abandoned by the Company in 2001 as part of its restructuring
plan. The lease had remaining term of 42 months at monthly rental rates of
$3,800 at the time the Company stopped paying rent on the lease. The Company is
attempting to negotiate a settlement with the landlord.
The Company carries insurance with coverages and coverage limits that it
believes to be customary in the dental industry. Although there can be no
assurance that such insurance will be sufficient to protect the Company against
all contingencies, management believes that its insurance protection is
reasonable in view of the nature and scope of the Company's operations.
The Company is from time to time subject to claims and suits arising in the
ordinary course of operations. In the opinion of management, the ultimate
resolution of such pending legal proceedings will not have a material adverse
effect on the Company's financial position, results of operations or liquidity.
7. Restructuring Costs and Other Charges
As discussed in Notes 1 and 2, the Company entered into a Restructuring
with its Senior Secured Lenders in July 2002. The Company had announced plans to
restructure the debt in the first quarter of 2001. Restructuring costs and other
charges related to the Restructuring the following:
Three Months Ended Six Months Ended
June 30, June 30,
--------------------- -------------------
2001 2002 2001 2002
------ ------ ------ -------
Legal and professional fees ............ $ 649 $ 624 $1,015 $ 945
Severance Costs ........................ 290 - 390 -
Remaining lease obligations on
closed dental centers ................ 384 34 384 239
------ ------ ------ ------
$1,323 $ 658 $1,789 $1,184
====== ====== ====== ======
8. Earnings Per Share:
Basic earnings per share for all periods presented equals net loss divided
by the weighted average number of shares of common stock outstanding during each
period. The effect of stock options and convertible debt was excluded from the
calculation of diluted loss per share for both periods because their effect
would have been anti-dilutive. The Company excluded 664,000 stock options and
442,800 shares related to convertible debt for the three and six month periods
of 2001 and 717,000 stock options and 442,800 shares related to convertible debt
for the three and six month periods of 2002.
9. Derivative Instruments and Hedging Activities
During June 1998, the Financial Accounting Standards Board issued SFAS No.
133, "Accounting for Derivative Instruments and Hedging Activities", which
requires that companies recognize all derivative instruments as either assets or
liabilities on the balance sheet and measure those instruments at fair value.
SFAS No. 137, "Accounting for Derivative Instruments and Hedging Activities -
Deferral of the Effective Date of FASB Statement No. 133," deferred the
implementation of SFAS 133 until the fiscal year ending December 31, 2001. The
Company implemented SFAS 133 effective January 1, 2001. During the three
12
month period ended March 31, 2001, the Company accrued $0.1 million in
additional interest expense under a hedging arrangement. The cumulative effect
of accounting change as of January 1, 2001, was a charge of $0.3 million, or
$0.03 per common share, that was reflected in the first quarter of 2001. The
term of the swap contract expired July 10, 2001.
10. Segment Information
The following table sets forth the financial information with respect to
the Company and its reportable segments:
Three Months Ended Six Months Ended
June 30, June 30,
------------------ -----------------
2001 2002 2001 2002
------- ------- ------- -------
Net patient revenues:
Texas.............................................. $16,472 $16,534 $35,336 $32,911
Florida............................................ 2,895 2,919 5,753 5,870
Tennessee.......................................... 2,853 2,931 5,813 6,113
California......................................... 2,284 2,762 5,325 5,740
------- ------- ------- -------
Total revenue...................................... 24,504 25,146 52,227 50,634
------- ------- ------- -------
Operating expenses:
Texas.............................................. 15,255 15,294 31,312 30,641
Florida............................................ 2,858 2,615 5,677 5,416
Tennessee.......................................... 2,825 2,520 5,433 5,128
California......................................... 2,141 2,491 4,505 4,822
Restructuring costs and other charges.............. 1,323 658 1,789 1,184
Corporate, general and administrative expenses..... 1,647 1,502 3,158 3,204
------- ------- ------- -------
Total operating expenses........................... 26,049 25,080 51,874 50,395
------- -------- ------- -------
Operating income (loss):
Texas.............................................. 1,217 1,240 4,024 2,270
Florida............................................ 37 304 76 454
Tennessee.......................................... 28 411 380 985
California......................................... 143 271 820 918
Restructuring costs and other charges.............. (1,323) (658) (1,789) (1,184)
Corporate, general and administrative expenses..... (1,647) (1,502) (3,158) (3,204)
------- ------- ------- -------
Total operating income (loss)...................... (1,545) 66 353 239
------- ------- ------- -------
Interest expense........................................... 2,158 1,645 4,358 3,273
Other income.............................................. (17) (180) (26) (193)
------- ------- ------- -------
Loss before provision for income taxes and
cumulative effect of change in accounting principles....... $(3,686) $(1,399) $(3,979) $(2,841)
======= ======= ======= =======
13
2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q contains forward-looking statements
within the meaning of the Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. The Company's actual results could differ
materially from those set forth in the forward-looking statements. Certain
factors that might cause such a difference include, among others, the changing
environment for dental health care, the pace of the Company's development and
acquisition activities, the reimbursement rates for dental services, and other
risk factors detailed in the Company's Securities and Exchange Commission
filings, including the Company's Form 10-K for the year ended December 31, 2001,
as filed with the U.S. Securities and Exchange Commission.
Overview
The Company develops, manages and operates integrated dental networks
through contractual affiliations with general, orthodontic and multi-specialty
dental practices in Texas, Florida, California and Tennessee. The Company does
not engage in the practice of dentistry but rather establishes integrated dental
networks through affiliations with dental practices providing quality care in
selected markets with a view to establishing broad geographic coverage within
those markets. The Company seeks to achieve operating efficiencies by
consolidating and integrating affiliated practices into regional networks,
realizing economies of scale in such areas as marketing, administration and
purchasing and enhancing the revenues of its affiliated dental practices by
increasing both patient visits and the range of specialty services offered. At
June 30, 2002, the Company managed 83 dental centers with approximately 188
affiliated dentists, orthodontists and specialists.
Components of Revenues and Expenses
Net patient revenues represent amounts billed by the affiliated dental
practices to patients and third-party payors for dental services rendered. Net
patient revenues are reported at established rates reduced by contractual
amounts based on agreements with patients, third-party payors and others
obligated to pay for services rendered.
Under the terms of the typical management services agreement with an
affiliated dental practice, the Company becomes the exclusive manager and
administrator of all non-dental services relating to the operation of the
practice. While actual terms of the various management service agreements may
vary from practice to practice, material aspects of all the management service
agreements, including the ability of the Company to nominate the majority
shareholder and the calculation of the management fees, are consistent. The
obligations of the Company include assuming responsibility for the operating
expenses incurred in connection with managing the dental centers. These expenses
include salaries, wages and related costs of non-dental personnel, dental
supplies and laboratory fees, rental and lease expenses, advertising and
marketing costs, management information systems, and other operating expenses
incurred at the dental centers. In addition to these expenses, the Company
incurs general and administrative expenses related to the billing and collection
of accounts receivable, financial management and control of the dental
operations, insurance, training and development, and other general corporate
expenditures.
Results of Operations
The following table sets forth the percentages of net patient revenues
represented by certain items reflected in the Company's Statement of Operations.
The information that follows should be read in conjunction with the Annual
audited Financial Statements and notes thereto of the Company included in the
Company's Form 10-K filed with the Securities and Exchange Commission, as well
as the Unaudited Consolidated Financial Information, included in this Form 10-Q.
14
Three Months Ended Six Months Ended
June 30, June 30,
-------------------- ----------------
2001 2002 2001 2002
------ ------ ------ ------
Net patient revenues......................................... 100.0% 100.0% 100.0% 100.0%
Expenses:
Dentist salaries and other professional costs.............. 27.1% 29.1% 26.8% 28.8%
Clinical salaries.......................................... 19.8% 21.9% 19.1% 22.1%
Dental supplies and laboratory fees........................ 11.7% 11.8% 11.1% 11.8%
Rental and lease expense................................... 6.9% 6.1% 6.5% 6.0%
Advertising and marketing.................................. 3.3% 1.8% 3.0% 2.6%
Depreciation and amortization.............................. 6.8% 3.6% 6.5% 3.6%
Other operating expenses................................... 7.4% 8.1% 7.1% 7.9%
Bad debt expense........................................... 4.8% 4.4% 4.4% 3.7%
Restructuring costs and other charges...................... 5.4% 2.6% 3.4% 2.3%
General and administrative................................. 11.1% 10.3% 10.3% 10.6%
Asset impairment........................................... 2.2% 0.0% 1.0% 0.2%
------ ------ ------ ------
Total expenses......................................... 106.3% 99.7% 99.3% 99.5%
------ ------ ------ ------
Operating income (loss)...................................... -6.3% 0.3% 0.7% 0.5%
Interest expense............................................. 8.8% 6.5% 8.3% 6.5%
Other (income) expense....................................... -0.1% -0.7% 0.0% -0.4%
------ ------ ------ ------
Loss before provision for income taxes and
cumulative effect of change in accounting principle........ -15.0% -5.6% -7.6% -5.6%
Provision for income taxes................................... 0.0% 0.0% 0.0% 0.0%
------ ------ ------ ------
Loss before cumulative effect of
change in accounting principle............................. -15.0% -5.6% -7.6% -5.6%
Cumulative effect of change in accounting principle.......... 0.0% 0.0% -0.5% -73.1%
------ ------ ------ ------
Net loss..................................................... -15.0% -5.6% -8.1% -78.7%
====== ====== ====== ======
Three Months Ended June 30, 2002 Compared to Three Months Ended June 30, 2001
Net Patient Revenues - Net patient revenues increased from $24.5 million
for the three months ended June 30, 2001, to $25.1 million for the same period
of 2002, an increase of $0.6 million or 2.6%. Patient revenues from dental
centers opened for more than one year increased approximately $1.8 million,
offset by $1.2 million from the closing of 17 dental centers since April 1,
2001.
Dentist Salaries and Other Professional Costs - Dentist salaries and other
professional costs consist primarily of compensation paid to dentists,
orthodontists, and hygienists employed by the affiliated dental practices.
Dentist salaries and other professional costs increased from $6.6 million for
the three months ended June 30, 2001 to $7.3 million for the three months ended
June 30, 2002, an increase of $0.7 million, or 10.5%. The increase is
attributable to increased dentist compensation and the hiring of additional
hygienists. Expressed as a percentage of net patient revenues, dentist salaries
and other professional costs increased from 27.1% to 29.1% for the three months
ended June 30, 2001 and 2002, respectively.
Clinical Salaries - Clinical salaries increased from $4.9 million for the
three months ended June 30, 2001 to $5.5 million for the three months ended June
30, 2002, an increase of $0.7 million or 13.6%. The increase is attributable to
the upgrading of dental office management and other personnel. Expressed as a
percentage of
15
net patient revenues, clinical salaries increased from 19.8% for the three
months ended June 30, 2001 to 21.9% for the comparable 2002 period.
Dental Supplies and Laboratory Fees - Dental supplies and laboratory fees
increased slightly, from $2.9 million for the three months ended June 30, 2001
to $3.0 million for the three months ended June 30, 2002, an increase of $0.1
million, or 3.6%. The slight increase is associated with the increase in
revenues. Expressed as a percentage of patient revenues, dental supplies and
laboratory fees were relatively unchanged, increasing from 11.7% for the three
months ended June 30, 2001 to 11.8% for the three months ended June 30, 2002.
Rental and Lease Expense - Rental and lease expense of $1.7 million for the
three months ended June 30, 2002 decreased by $0.2 million, or 8.5%, from the
second quarter of 2001. The closing of six dental centers over the past year
accounted for the decrease. Expressed as a percentage of net patient revenues,
rental and lease expense decreased from 6.9% for the three months ended June 30,
2001 to 6.1% for the three-month period ended June 30, 2002.
Advertising and Marketing - Advertising and marketing expenses decreased
from $0.8 million in the second quarter of 2001 to $0.5 million in the same
period of 2002, a decrease of $0.3 million, or 42.0%. Reduced expenditures on
television advertising in the second quarter of 2002 accounted for the decrease.
Expressed as a percentage of net patient revenues, advertising and marketing
expenses decreased from 3.3% in the prior year period to 1.8% for the three
months ended June 30, 2002.
Depreciation and Amortization - Depreciation and amortization decreased
from $1.7 million for the three months ended June 30, 2001, to $0.9 million for
the three months ended June 30, 2002, a decrease of 0.8 million or 45.9%.
Effective January 1, 2002, the Company adopted Statement of Financial Accounting
Standard No. 142 ("SFAS 142"), Goodwill and Other Intangible Assets and
reclassified approximately $54.9 million from management services agreements to
goodwill, and as required by SFAS 142, the Company no longer records
amortization expenses related to this goodwill. The effect of this change
reduced the loss before cumulative effect of change in accounting principle by
approximately $0.7 million, or $0.10 per share for the three months ended June
30, 2002. Had the Company adopted SFAS 142 effective January 1, 2001, the effect
would have been to reduce the loss before cumulative effect of change in
accounting principle by approximately $0.7 million, or $0.11 per share for the
three months ended June 30, 2001. In the second quarter of 2002, the Company
completed its quantification of the impairment charge and recorded a $37.0
million impairment charge, related to the write-down of its goodwill, as a
cumulative effect of change in accounting principle effective January 1, 2002.
The remainder of the decrease resulted from the closing of five centers over the
past year. Expressed as a percentage of net patient revenues, depreciation and
amortization decreased from 6.8% in the prior year period to 3.6% for the three
months ended June 30, 2002.
Other Operating Expenses - Other operating expenses increased slightly from
$1.8 million for the three months ended June 30, 2001, to $2.0 million for the
three months ended June 30, 2002, an increase of $0.2 million or 12.0%. Other
operating expenses represent expenses related to the operation of the Company's
dental centers. The increase is attributable primarily to higher communication
costs, printing costs associated with patient surveys, increased doctor
recruitment fees and collector fees. Expressed as a percentage of net patient
revenues, other operating expenses increased from 7.4% for the three months
ended June 30, 2001 to 8.1% for the comparable 2002 period.
Bad Debt Expense - Bad debt expense of $1.1 million for the three months
ended June 30, 2002 decreased by $0.1 million, or 5.0%. Expressed as a
percentage of net patient revenues, bad debt expense decreased from 4.8% for the
three months ended June 30, 2001 to 4.4% for the same period of 2002. The
decrease is attributable to improved collection efforts during the comparable
periods.
Restructuring Costs and Other Charges - For the three months ended June 30,
2002 the Company recorded restructuring costs and other charges of $0.7 million
attributable primarily to legal and professional fees related to the
restructuring of the Company's senior credit facility. For the three months
ended June 30, 2001 the Company recorded restructuring costs of $1.3 million
including severance costs, remaining lease
16
obligations on closed offices, and legal and professional fees related to the
implementation of the plan to improve operating results and restructure the
Company's credit facilities.
General & Administrative Expense - General and administrative expenses of
$2.6 million for the three months ended June 30, 2002 decreased by 5.0% from
general and administrative expenses of $2.7 million in the second quarter of
2001. Expressed as a percentage of net patient revenues, general and
administrative expense decreased from 11.1% for the three months ended June 30,
2001 to 10.3% for the comparable period of 2002. The decrease in general and
administrative expenses is attributable to reductions in corporate and regional
support staff.
Interest Expense - Interest expense decreased from $2.2 million for the
three months ended June 30, 2001 to $1.6 million for the three months ended June
30, 2002, a decrease of $0.5 million or 23.8%. The decrease resulted from a
decrease in the variable interest rate under the bank credit facility and senior
subordinated note agreements.
Six Months Ended June 30, 2002 Compared to Six Months Ended June 30, 2001
Net Patient Revenue - Net patient revenues decreased from $52.2 million for
the six months ended June 30, 2001 to $50.6 million for the same period of 2002,
a decrease of $1.6 million or 3.1%. Patient revenues for dental centers open for
more than one year increased approximately $0.9 million, or 1.7%, from the
second quarter of 2001, offset by a decrease in revenues of approximately $2.7
million, or 5.2%, from the closure of 18 dental centers since January 2001.
Dentist Salaries and Other Professional Costs - For the six months ended
June 30, 2002, dentist salaries and other professional costs were $14.6 million,
$0.6 million, or 4.3% higher than dentist salaries and other professional costs
of $14.0 million during the same period in 2001. Higher dentist compensation and
increased hiring of hygienists accounted for the increase. Expressed as a
percentage of net patient revenues, dentist salaries and other professional
costs increased from 26.8% to 28.8% for the six months ended June 30, 2001 and
2002, respectively.
Clinical Salaries - Clinical salaries increased from $10.0 million for the
six months ended June 30, 2001 to $11.2 million for the six months ended June
30, 2002, an increase of $1.2 million or 11.8%. The increase is attributable to
higher compensation associated with the upgrading of dental office management
and other personnel. Expressed as a percentage of net patient revenues, clinical
salaries increased from 19.1% in the first six months of 2001 to 22.1% for the
same period of 2002.
Dental Supplies and Laboratory Fees - Dental supplies and laboratory fees
increased from $5.8 million for the six months ended June 30, 2001 to $6.0
million for the six months ended June 30, 2002, an increase of $0.2 million or
2.7%. Higher laboratory fees resulting from price increases and outsourcing of
certain lab functions accounted for the increase. Expressed as a percentage of
patient revenues, dental supplies and laboratory fees increased from 11.1% for
the six months ended June 30, 2001 to 11.8% for the six months ended June 30,
2002.
Rental and Lease Expense - Rental and lease expense of $3.1 million for the
six months ended June 30, 2002 decreased by $0.3 million, or 10.3% from the
first six months of 2001. The decrease is attributable to the closing of 18
dental centers since January 2001. Expressed as a percentage of net patient
revenues, rent and lease expense decreased from 6.5% for the six months ended
June 30, 2001 to 6.0% for the six-month period ended June 30, 2002.
Advertising and Marketing - Advertising and marketing expenses decreased
from $1.6 million in the first half of 2001 to $1.3 million during the first
half of 2002, a decrease of $0.3 million, or 18.1%. Lower expenditures on
television advertising accounted for the decrease. Expressed as a percentage of
net patient revenues, advertising and marketing expenses decreased from 3.0% in
the prior year period to 2.6% for the six months ended June 30, 2002.
17
Depreciation and Amortization - Depreciation and amortization decreased
from $3.4 million for the six months ended June 30, 2001, to $1.8 million for
the six months ended June 30, 2002, a decrease of $1.6 million or 46.5%.
Effective January 1, 2002, the Company adopted Statement of Financial Accounting
Standard No. 142 ("SFAS 142"), Goodwill and Other Intangible Assets and
reclassified approximately $54.9 million from management services agreements to
goodwill, and as required by SFAS 142, the company no longer records
amortization expenses related to this goodwill. The effect of this change
reduced the loss before cumulative effect of change in accounting principle by
approximately $1.3 million, or $0.20 per share, for the six months ended June
30, 2002. Had the Company adopted SFAS 142 effective January 1, 2001, the effect
would have been to reduce the loss before cumulative effective of change in
accounting principle by approximately $1.4 million, or $0.21 per share for the
six months ended June 30, 2001. In the second quarter of 2002, the Company
completed its quantification of the impairment charge and recorded a $37.0
million impairment charge, related to the write-down of goodwill, as a
cumulative effect of change in accounting principle effective January 1, 2002.
The remainder of the decrease resulted from the closing of six centers over the
past year. Expressed as a percentage of net patient revenues, depreciation and
amortization decreased from 6.5% in the prior year period to 3.6% for the six
months ended June 30, 2002.
Other Operating Expenses - Other operating expenses increased from $3.7
million for the six months ended June 30, 2001, to $4.0 million for the six
months ended June 30, 2002, an increase of $0.3 million or 7.3%. The increase is
attributable primarily to higher communication costs, printing cost associated
with patient surveys, increased doctor recruitment fees and collector fees.
Expressed as a percentage of net patient revenues, other operating expenses
increased from 7.1% for the six months ended June 30, 2001 to 7.9% for the
comparable 2002 period.
Bad Debt Expense - Bad debt expense of $2.3 million for the six months
ended June 30, 2001 decreased $0.4 million, or 18.5% to $1.9 million for the
same period of 2002. Expressed as a percentage of net patient revenues, bad debt
expense decreased from 4.4% for the six months ended June 30, 2001 to 3.7% for
the same period of 2002. The decrease is attributable to increased collection
efforts for the comparable periods.
Restructuring Costs and Other Charges - For the six months ended June 30,
2002, the Company recorded restructuring costs and other charges of $1.2 million
attributable primarily to legal and professional fees related to the
restructuring of the Company's senior credit facility and remaining lease
obligations on closed dental centers. For the six months ended June 30, 2001 the
Company recorded restructuring costs of $1.8 million including severance costs,
remaining lease obligations on closed dental centers and legal and professional
fees related to the implementation of the plan to improve operating results and
restructure the Company's credit facilities.
General & Administrative Expense - General and administrative expenses of
$5.4 million for the six months ended June 30, 2002 were unchanged from the
prior year period. Expressed as a percentage of net patient revenues, general
and administrative expense increased slightly from 10.3% to 10.6% for the six
months ended June 30, 2001 and 2002, respectively.
Interest Expense - Interest expense decreased from $4.4 million for the six
months ended June 30, 2001 to $3.3 million for the six months ended June 30,
2002, a decrease of $1.1 million or 24.9%. The decrease resulted from a decrease
in the variable interest rate under the bank credit facility.
Cumulative Effect of Change in Accounting Principle - In connection with
the Company's adoption of SFAS 142, the Company recorded a $37.0 million
transitional goodwill impairment charge at the beginning of the fiscal year.
(See Note 3 of Notes to Condensed Consolidated Financial Statements).
During June 1998, the Financial Accounting Standards Board issued SFAS No.
133, "Accounting for Derivative Instruments and Hedging Activities", which
requires that companies recognize all derivative instruments as either assets or
liabilities on the balance sheet and measure those instruments at fair value.
SFAS No. 137, "Accounting for Derivative Instruments and Hedging Activities -
Deferral of the Effective Date of FASB Statement No. 133," deferred the
implementation of SFAS 133 until the fiscal year ending December 31, 2001. The
Company implemented SFAS 133 effective January 1, 2001, resulting in a
cumulative effect adjustment of $0.3 million during the first half of 2001
18
Liquidity and Capital Resources
At June 30, 2002 the Company had a net working capital deficit of $6.8
million. Current assets consisted of cash and cash equivalents of $2.0 million,
billed and unbilled accounts receivable of $8.5 million and prepaid expenses and
other current assets of $2.0 million. Current liabilities totaled $19.3 million,
consisting of $18.0 million in accounts payable and accrued liabilities, $0.1
million deferred compensation payable and $1.1 million in current maturities of
long-term debt.
For the six months ended June 30, 2002, cash used in operating activities
was $1.0 million. In the six months ended June 30, 2001, cash provided by
operating activities amounted to $3.3 million. For the six months ended June 30,
2002 and 2001 cash used in investing activities was $0.6 million and $0.3
million, respectively, consisting primarily of capital expenditures. For the six
months ended June 30, 2002, cash used in financing activities totaled $0.3
million representing $0.1 million, for repayments of long-term debt and capital
lease obligations and $0.2 million in debt and equity issuance costs. For the
six months ended June 30, 2001, cash used in financing activities totaled $0.2
million, representing repayments of long-term debt and capital lease
obligations. The Company has budgeted $1.3 million in capital commitments for
the remainder of 2002, which it expects to fund through internally generated
funds.
During the first six months of 2002, the Company's principal sources of
liquidity consisted primarily of cash and cash equivalents and net accounts
receivable. Since June 2000, the Company has been in default under the Old
Credit Agreement with the Senior Secured Lenders; the Senior Subordinated Notes
issued to the Senior Subordinated Lenders; and the Old Notes. On July 19, 2002,
the Company entered into a restructuring (the "Restructuring") with its Senior
Secured Lenders and its Senior Subordinated Lenders regarding the debt
outstanding under the Old Credit Agreement, the Senior Subordinated Notes and
the Old Notes. Pursuant to the Restructuring, the Company has:
. exchanged 32,002 shares Series A-1 Stock (Note 4) for $3,624,771 in
aggregate principal and interest of its Old Notes;
. exchanged 179,280 shares of Series A-1 Stock for $17,928,000 in
aggregate principal and interest of the Senior Subordinated Notes;
. amended and restated the Old Credit Agreement (Note 4);
. issued warrants to purchase 60,859 shares of Series A-2 (Note 4) to
the Senior Secured Lenders;
. borrowed $1,700,000 from the New Money Lenders;
. issued convertible notes with an aggregate principal amount of
$1,700,000 evidencing the amount borrowed from the New Money
Lenders which notes are initially convertible into 3,105,618 shares
of the Company's Common Stock, interest at 15% is due quarterly and
principal is due June 30, 2007;
. issued warrants to purchase 17,974,062 shares of Common Stock to
the New Money Lenders.
The Company expects to recognize a gain of approximately $16.0 million in
the third quarter of 2002 as part of the Restructuring.
In connection with the Restructuring, the Company entered into settlement
agreements ("Settlement Agreements") with Jack H. Castle, Jr. and the estate of
Jack H. Castle, D.D.S. Mr. Castle served as our Chief Executive Officer until
February 2001 and continued as our Chairman of the Board until July 1, 2001. Dr.
Castle owned all of the capital stock of Castle Dental Associates of Texas, P.C.
(formerly Jack H. Castle, D.D.S., P.C.), the professional corporation that
employs the affiliated dentists in the State of Texas (the "Texas PC"), until
his death in May 2002, at which time a successor owner of the Texas PC was
appointed.
The Settlement Agreements provided for mutual releases of any claims that
either party may have had, as well as the following terms: (i) Dr. Castle's
estate waived the right to receive the final payment of $0.1 million due under a
deferred compensation agreement; (ii) the Company paid Mr. Castle severance of
through June 30, 2002 of approximately $0.3 million, reimbursed him for medical
insurance and forgave $45,000 of debt Mr. Castle owed to the Company; (iii) in
August 2002, Mr. Castle acquired two offices located in Corpus Christi and one
office located in Beaumont and the Company paid Mr. Castle an additional $54,000
of expenses; and (iv) effective June 30, 2002, the Company terminated a lease of
19
a property held by Goforth, Inc., which is owned by Mr. Castle, that required
payments of approximately $16,000 per month and had a remaining term of
approximately five years.
In connection with the Restructuring, the Company entered into a Second
Amended and Restated Credit Agreement ("Credit Agreement") with the Senior
Secured Lenders. Pursuant to the terms of the Credit Agreement, the aggregate
unpaid principal balance of the Old Credit Agreement amounting to $45.2 million
plus accrued and unpaid default interest and other obligations of $2.2 million
have been converted to a term loan in the amount of $47.4 million. Principal of
the Credit Agreement is payable quarterly in installments of $0.5 million
beginning March 31, 2003, increasing to $1.0 million March 31, 2004, and $1.6
million March 31, 2005 with a final payment of the remaining principal balance
due July 19, 2005. As defined in the Credit Agreement, the Company is required
to make an annual cash flow payment and other mandatory prepayments. Interest,
payable monthly, is computed at the bank's prime rate plus two percent. An
administrative fee of $25,000 is payable annually with the first payment due on
July 19, 2002. Fees include (1) a one percent restructuring fee totaling
approximately $0.5 million, which is payable in four quarterly installments of
$0.1 million plus accrued interest at the bank's prime rate plus two percent,
beginning September 19, 2002 and (2) a four percent financing fee amounting to
approximately $1.9 million, which will be payable in full, without interest, on
July 19, 2005. The Credit Agreement contains affirmative and negative covenants
that require the Company to maintain certain financial ratios, limit the amount
of additional indebtedness, limit the creation or existence of liens, set
certain restrictions on acquisitions, mergers and sales of assets and restrict
the payment of dividends.
At June 30, 2002, $45.2 million was outstanding under the Old Credit
Agreement. The balance has been classified between current and long-term based
upon the payment terms of the Credit Agreement entered into in July 2002. At
June 30, 2002, $15.0 million in principal was outstanding under the Senior
Subordinated Notes and $3.2 million in principal was outstanding under the Old
Notes. These balances have been classified as long-term as they are converted to
equity in July 2002, therefore, there is no current payment obligation under
these notes.
The following table summarizes, as of June 30, 2002, our contractual
commitments related to debt, leases and other arrangements during the next five
years (in thousands):
Twelve Months Ended June 30,
-------------------------------------------------------------
2003 2004 2005 2006 2007 Thereafter
-------- -------- -------- -------- ------- ----------
Long-Term Debt... 1,135 3,009 3,628 37,605 - -
Operating Leases. 5,134 4,792 3,852 3,096 2,402 2,349
Approximately $18.2 million in outstanding debt at June 30, 2002, has
been excluded from the table as it is converted to equity on July 19, 2002, as
part of the Restructuring
Recent Accounting Pronouncements
On August 16, 2001, the Financial Accounting Standards Board issued
SFAS 143, "Accounting for Asset Retirement Obligation". SFAS 143 addresses
financial accounting and reporting for obligations associated with the
retirement of tangible long-lived assets and the associated asset retirement
costs. These provisions of SFAS 143 are effective for financial statements
issued for fiscal years beginning after June 15, 2002. Earlier application is
encouraged. Management believes the application of SFAS 143 will not have a
material effect on the Company.
On October 3, 2001, the Financial Accounting Standards Board issued SFAS
144, "Accounting for the Impairment or Disposal of Long-Lived Assets". SFAS 144
addresses financial accounting and reporting for the impairment or disposal of
long-lived assets. This Statement supercedes SFAS 121, "Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of" and
the accounting and reporting provisions of APB Opinion No. 30, "Reporting the
Results of Operations-Reporting the Effects of Disposal of a Segment of a
Business, and Extraordinary, Unusual and Infrequently Occurring Events and
Transactions", both of which address the disposal of a segment of a business.
The provisions of SFAS 144 are effective for financial statements issued for
fiscal years beginning after December 15, 2001 and interim periods within those
fiscal years, with early application encouraged. The Company is currently
evaluating the impact of the adoption of this Statement but does not believe it
will have a material impact on the Company's net income, cash flows, or
financial condition.
In May 2002, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 145 ("SFAS 145"), "Rescission of FAS Nos. 4,
44, and 64, Amendment of FAS 13, and Technical Corrections as of April 2002."
This Statement rescinds FASB Statement No. 4, Reporting Gains and Losses from
Extinguishment of Debt, and an amendment of that Statement, FASB Statement No.
64, Extinguishment of Debt Made to Satisfy Sinking-Fund Requirements. This
Statement also rescinds FASB Statement No. 44, Accounting for Intangible Assets
of Motor Carriers. This Statement also amends other
20
existing authoritative pronouncements to make various technical
corrections, clarify meanings, or describe their applicability under changed
conditions. The Company is currently evaluating the impact of the adoption of
this Statement but does not believe it will have a material impact on the
Company's net income, cash flows, or financial condition.
In July 2002, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 146 ("SFAS 146") "Accounting for Costs
Associated with Exit or Disposal Activities. SFAS 146 requires that a liability
for a cost associated with an exit or disposal activity be recognized when the
liability is incurred rather than at the date of a commitment to an exit or
disposal plan. Examples of costs covered by this guidance include termination
benefits provided to current employees that are involuntarily terminated under
the terms of a benefit arrangement that, in substance, is not an ongoing benefit
arrangement or an individual deferred compensation contract, costs to terminate
a contract that is not a capital lease, costs to consolidate facilities or
relocate employees. The provisions of SFAS 146 are effective for exit or
disposal activities that are initiated after December 31, 2002, with earlier
application encouraged. The Company is currently evaluating the impact of the
adoption of this Statement but does not believe it will have a material impact
on the Company's net income, cash flows, or financial condition.
Item 3. Quantitative and Qualitative Disclosures About Market Risks
The Company's financial instruments with market risk exposure are
borrowings under the Credit Agreement and Senior Subordinated Notes, which total
$60.2 million at June 30, 2002. Based on this balance, a change of one percent
in the interest rate would cause a change in interest expense of approximately
$602,000, or $0.09 per share, on an annual basis. The bank credit facility was
not entered into for trading purposes and carries interest at a pre-agreed upon
percentage point spread from either the prime interest rate or Eurodollar
interest rate.
PART II -- OTHER INFORMATION
Item 1. Legal Proceedings
On May 30, 2002, litigation was filed in the Circuit Court for Putnam
County, Tennessee against the Company and one of its subsidiaries by the spouse
and children of a patient of an affiliated dental practice alleging that the
defendants were negligent and vicariously liable in the care and treatment of
the patient, resulting in his death. The lawsuit seeks damages in the amount of
$10 million, in excess of the policy limits of $1.0 million per occurrence
carried by the Company. The Company has filed a response to the litigation
denying liability in this matter and intends to vigorously defend itself.
Discovery has not yet commenced in the case and, at this time, the Company
cannot determine what liability, if any, may be assessed against it and
therefore has not recorded any liability in this matter. A finding against the
Company in excess of the insurance policy limits could have a material adverse
effect on the Company.
In 2000, the Company recorded litigation expenses of $1.5 million resulting
from an arbitration award against two subsidiaries of the Company in an
arbitration proceeding in Los Angeles, California. The arbitrator found that the
subsidiaries had breached a contractual agreement to acquire a dental practice
and awarded the plaintiffs actual damages and costs of $1.1 million, plus
interest at 10 percent from the date that the judgment was filed. In connection
with the July 2002 Restructuring, the Company entered into a forbearance
agreement with the plaintiffs regarding this judgment. The Company has agreed
that in exchange for forbearance in enforcing the judgment the Company will make
the following payments (1) $100,000 interest payment in July 2002, (2)
twenty-three monthly installments of $30,000 each and (3) then $25,000 monthly
installments until paid in full.
In October 2001, the former owners of Dental Centers of America filed suit
in Bexar County, Texas alleging that the Company breached a letter agreement
offering payment as settlement for past due amounts on two subordinated
promissory notes that were part of the purchase consideration for Dental Centers
of America. The plaintiffs obtained a judgment for $625,000 plus interest and
attorneys' fees, against the Company. In connection with the Restructuring the
suit was settled.
The Company also is a defendant in a lawsuit with a landlord of a leased
property that was abandoned by the Company in 2001 as part of its restructuring
plan. The lease had remaining term of 42 months at monthly rental rates of
$3,800 at the time the Company stopped paying rent on the lease. The Company is
attempting to negotiate a settlement with the landlord.
21
The Company carries insurance with coverages and coverage limits that it
believes to be customary in the dental industry. Although there can be no
assurance that such insurance will be sufficient to protect the Company against
all contingencies, management believes that its insurance protection is
reasonable in view of the nature and scope of the Company's operations.
The Company is from time to time subject to claims and suits arising in
the ordinary course of operations. In the opinion of management, the ultimate
resolution of such pending legal proceedings will not have a material adverse
effect on the Company's financial position, results of operations or liquidity.
Item 2. Changes in Securities and Use of Proceeds.
Since June 2000, the Company has been in default under:
. the Old Credit Agreement with the Senior Secured Lenders;
. The Senior Subordinated Notes issued to the Senior Subordinated
Lenders; and
. the Old Notes.
On July 19, 2002, the Company entered into the Restructuring. Pursuant
to the Restructuring, the Company has:
. exchanged 32,002 shares of Series A-1 Stock, for $3,624,771 in
aggregate principal and interest of its Old Notes;
. exchanged 179,280 shares of Series A-1 Stock for $17,928,000 in
aggregate principal and interest of the Senior
Subordinated Notes;
. amended and restated the Old Credit Agreement;
. issued warrants to purchase 60,859 shares of Series A-2 Stock to
the Senior Secured Lenders;
. borrowed $1,700,000 from the New Money Lenders;
. issued convertible notes with an aggregate principal amount of
$1,700,000 evidencing the amount borrowed from the New Money
Lenders which notes are initially convertible into 3,105,618 shares
of the Company's Common Stock, interest at 15% is due quarterly and
principal is due June 30, 2007; and
. and issued warrants to purchase 17,974,062 shares of Common Stock
to the New Money Lenders.
Each of the foregoing transactions was exempt from registration under
Section 4(2) of the Securities Act, no public offering being involved.
Each share of Series A-1 Stock and Series A-2 Stock is immediately
convertible into approximately 182.7 shares of Common Stock. The warrants to
purchase shares of Series A-2 Stock have a term of ten years and are exercisable
at $.001 per share. The warrants to purchase shares of Common Stock have a term
of ten years and are exercisable at $.001 per share. Principal and interest
outstanding on the convertible notes issued to the New Money Lenders is
convertible into Common Stock at any time at approximately $.5474 per share.
Item 3. Defaults Upon Senior Securities.
Since June 2000, the Company has been in default under:
. the Old Credit Agreement Senior Secured Lenders;
. the Senior Subordinated Notes issued to the Senior Subordinated
Lenders;
. the Old Notes.
On July 19, 2002, the Company entered into the Restructuring
22
(see Note 2 of Notes to Condensed Consolidated Financial Statements). All
existing defaults under such agreements were cured or waived in connection with
the Restructuring.
Item 4. Submission of Matters to a Vote of Security Holders.
None
Item 5. Other Information.
Not applicable.
Item 6. Exhibits and Reports on Form 8-K.
The following exhibits are filed with this report:
(a) Articles of Incorporation and By-laws
3.1 Amended and Restated Certificate of
Incorporation of Castle Dental Centers, Inc.
(incorporated by reference from Exhibit 3.1
of the Company's Annual Report on Form 10-K
for the period ended December 31, 2001, File
No. 001-13263)
3.2 Amended and Restated Bylaws (incorporated by
reference from Exhibit 3.2 of the Company's
Current Report on Form 8-K dated August 5,
2002, File No. 001-13263)
3.3 Certificate of Designations, Preferences and
Rights of Series A-1 Convertible Preferred
Stock and Series A-2 Convertible Preferred
Stock of Castle Dental Centers, Inc.
(incorporated by reference from Exhibit 3.1
of the Company's Current Report on Form 8-K
dated August 5, 2002, File No.
001-13263)
4. Instruments defining the rights of security holders,
including indentures.
4.1 Form of Certificate representing the Common
Stock, par value $.001 per share, of Castle
Dental Centers, Inc. (incorporated by
reference to Exhibit 4.1 of the Company's
Registration Statement on Form S-1, filed
September 3, 1996, Reg. No. 333-1335)
4.2 Registration Rights Agreement dated December
18, 1995, among Castle Dental Centers, Inc.
and Delaware State Employees' Retirement
Fund, Declaration of Trust for Defined
Benefit Plan of ICI American Holdings, Inc.,
Declaration of Trust for Defined Benefit
Plan of Zeneca Holdings, Inc. and certain
stockholders and investors in the Company
(incorporated by reference to Exhibit 4.2 of
the Company's Registration Statement on Form
S-1, filed September 3, 1996, Reg. No.
333-1335)
4.3 Stockholders Agreement by and among Castle
Dental Centers, Inc., Bank of America
Strategic Solutions, Inc., FSC Corp.,
Amsouth Bank, Heller Financial, Inc.,
Midwest Mezzanine Fund II, L.P., and James
M. Usdan (incorporated by reference from
Exhibit 10.8 of the Company's Current Report
on Form 8-K dated August 5, 2002, File No.
001-13263)
23
4.4 Registration Rights Agreement dated July 19,
2002 (incorporated by reference from Exhibit
10.10 of the Company's Current Report on
Form 8-K dated August 5, 2002, File No.
001-13263)
4.5 Investors Agreement, dated as of July 19,
2002, by and among Castle Dental Centers,
Inc., Heller Financial, Inc., Midwest
Mezzanine Fund II, L.P., and James M. Usdan
(incorporated by reference from Exhibit 10.9
of the Company's Current Report on Form 8-K
dated August 5, 2002, File No. 001-13263)
10. Material Contracts
10.1 Second Amended and Restated Credit Agreement
among Castle Dental Centers, Inc., Bank of
America, N.A. and the Lenders dated as of
July 19, 2002 (incorporated by reference
from Exhibit 10.1 of the Company's Current
Report on Form 8-K dated August 5, 2002,
File No. 001-13263)
10.2 Form of Warrant Agreement among the Company
and the Lenders (incorporated by reference
from Exhibit 10.2 of the Company's Current
Report on Form 8-K dated August 5, 2002,
File No. 001-13263)
10.3 Senior Subordinated Note and Warrant
Purchase Agreement dated as of July 19,
2002, among Castle Dental Centers, Inc.,
Heller Financial, Inc., Midwest Mezzanine
Fund II, L.P., and James M. Usdan
(incorporated by reference from Exhibit 10.3
of the Company's Current Report on Form 8-K
dated August 5, 2002, File No. 001-13263)
10.4 Form of Warrant Agreement among the Company
and the New Money Lenders (incorporated by
reference from Exhibit 10.4 of the Company's
Current Report on Form 8-K dated August 5,
2002, File No. 001-13263)
10.5 Form of Convertible Note among the Company
and the New Money Lenders (incorporated by
reference from Exhibit 10.5 of the Company's
Current Report on Form 8-K dated August 5,
2002, File No. 001-13263)
10.6 Subordination and Intercreditor Agreement
dated July 19, 2002, by and among Heller
Financial, Inc., Midwest Mezzanine Fund II,
L.P., James M. Usdan, Castle Dental Centers,
Inc., Castle Dental Centers of California,
L.L.C., Castle Dental Centers of Florida,
Inc., Castle Dental Centers of Tennessee,
Inc., Castle Dental Centers of Texas, Inc.,
Dentcor, Inc., CDC of California, Inc.,
Castle Texas Holdings, Inc. and Academy for
Dental Assistants, Inc. (incorporated by
reference from Exhibit 10.6 of the Company's
Current Report on Form 8-K dated August 5,
2002, File No. 001-13263)
10.7 Senior Subordinated Note and Subordinated
Convertible Note Exchange Agreement dated as
of July 19, 2002 among Castle Dental
Centers, Inc., Heller Financial, Inc. and
Midwest Mezzanine Fund II, L.P.
(incorporated by reference from Exhibit 10.7
of the Company's Current Report on Form 8-K
dated August 5, 2002, File No. 001-13263)
10.8 Form of Exchange Agreement with Holders of
Seller Notes (incorporated by reference from
Exhibit 10.11 of the Company's Current
Report on Form 8-K dated August 5, 2002,
File No. 001-13263)
24
10.9 Forbearance Agreement dated as of July 17,
2002, by and between Leon D. Roisman, D.M.D,
Leon D. Roisman, D.M.D, Inc., Roisman
Acquisition Company, CDC of California, Inc.
and Castle Dental Centers of California,
L.L.C. (incorporated by reference from
Exhibit 10.12 of the Company's Current
Report on Form 8-K dated August 5, 2002,
File No. 001-13263)
10.10 Settlement Agreement between Jack H. Castle,
D.D.S. and the Estate of Jack H. Castle,
D.D.S., Castle Dental Centers, Inc., Castle
Dental Centers of Texas, Inc., Castle Dental
Associates of Texas, P.C., Castle Interests,
Ltd., and Loretta M. Castle (incorporated by
reference from Exhibit 10.13 of the
Company's Current Report on Form 8-K dated
August 5, 2002, File No. 001-13263)
10.11 Severance Agreement between Jack H. Castle,
Jr., the Company, Goforth, Inc. and Castle
1995 Gift Trust (incorporated by reference
from Exhibit 10.14 of the Company's Current
Report on Form 8-K dated August 5, 2002,
File No. 001-13263)
10.12 Castle Dental Centers 2002 Stock Option Plan
(incorporated by reference from Exhibit
10.15 of the Company's Current Report on
Form 8-K dated August 5, 2002, File No.
001-13263)
10.13 Employment Agreement by and between James M.
Usdan and the Company (incorporated by
reference from Exhibit 10.16 of the
Company's Current Report on Form 8-K dated
August 5, 2002, File No. 001-13263)
11. Statement re computation of per share earnings*
15. Letter re unaudited interim financial information*
18. Letter re change in accounting principles*
19. Report furnished to security holders*
22. Published report regarding matters submitted to vote
of security holders*
23. Consents of experts and counsel*
24. Power of attorney*
99. Additional exhibits
99.1 Copy of Castle Dental Centers, Inc.'s Press Release
dated July 22, 2002 (incorporated by reference
from Exhibit 99.1 of the Company's Current Report
on Form 8-K dated August 5, 2002, File No.
001-13263)
______________________
*Inapplicable to this filing
(b) Reports on Form 8-K
25
Current Report on Form 8-K dated August 5, 2002, reporting
Item 1 Change in Control of Registrant was filed August 5,
2002.
26
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CASTLE DENTAL CENTERS, INC.
Date: August 19, 2002 /s/ JAMES M. USDAN
----------------------------
James M. Usdan
Chief Executive Officer
Date: August 19, 2002 /s/ JOSEPH P. KEANE
----------------------------
Joseph P. Keane
Chief Financial Officer
27